HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

S2X259

Also Known As:

S2-259; S2259

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Abdelnabi, Rana: 1 article (01/2021)
2.	Addetia, Amin: 1 article (01/2021)
3.	Bartha, Istvan: 1 article (01/2021)
4.	Beltramello, Martina: 1 article (01/2021)
5.	Benigni, Fabio: 1 article (01/2021)
6.	Bloom, Jesse D: 1 article (01/2021)
7.	Bowen, John E: 1 article (01/2021)
8.	Cameroni, Elisabetta: 1 article (01/2021)
9.	Corti, Davide: 1 article (01/2021)
10.	Culap, Katja: 1 article (01/2021)

Related Diseases

1.

04/08/2021 - "We show that prophylactic administration of S2X259 protects Syrian hamsters against challenges with the prototypic SARS-CoV-2 and the B.1.351 variant, suggesting this mAb is a promising candidate for the prevention and treatment of emergent VOC and zoonotic infections. "
01/01/2021 - "We show that prophylactic and therapeutic administration of S2X259 protects Syrian hamsters (Mesocricetus auratus) against challenge with the prototypic SARS-CoV-2 and the B.1.351 variant of concern, which suggests that this monoclonal antibody is a promising candidate for the prevention and treatment of emergent variants and zoonotic infections. "

Related Drugs and Biologics

1.	Monoclonal Antibodies